VanEck Associates
ICUI icon

VanEck Associates’s ICU Medical ICUI Stock Holding History

VanEck Associates’s Portfolio ICUI Stock Details ICUI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-2,103
Closed -$347K – 1431
2023
Q1 		$347K Sell
2,103
-580
-22% -$99.8K ﹤0.01% 1074
2022
Q4 		$423K Buy
2,683
+2,124
+380% +$323K ﹤0.01% 953
2022
Q3 		$84K Buy
559
+50
+10% +$8.32K ﹤0.01% 1204
2022
Q2 		$84K Buy
509
+40
+9% +$7.7K ﹤0.01% 1248
2022
Q1 		$104K Buy
469
+65
+16% +$14.6K ﹤0.01% 1229
2021
Q4 		$96K Buy
404
+24
+6% +$5.61K ﹤0.01% 1254
2021
Q3 		$89K Buy
380
+141
+59% +$29.6K ﹤0.01% 1169
2021
Q2 		$49K Buy
239
+128
+115% +$26.3K ﹤0.01% 1201
2021
Q1 		$23K Buy
+111
New +$23.4K ﹤0.01% 1170

Other funds holding ICUI

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VanEck Associates's ICUI Position: Q2 2023 in Review

VanEck Associates sold out of ICU Medical (ICUI) in Q2 2023, closing a stake of 2,103 shares — an estimated $347K sold.

VanEck Associates first reported a position in ICUI in Q1 2021 and held it in 9 quarters. The position peaked at $423K in Q4 2022. 231 funds tracked by Wall St. Rank hold ICUI as of Q2 2023.

  • VanEck Associates reported no remaining ICU Medical position as of Q2 2023 after selling out during the quarter.
  • VanEck Associates sold 2,103 ICU Medical shares in Q2 2023, an estimated $347K.
  • VanEck Associates first reported a position in ICU Medical in Q1 2021 and held it in 9 quarters.
  • VanEck Associates's ICU Medical position peaked at $423K in Q4 2022.
  • 231 funds tracked by Wall St. Rank held ICU Medical as of Q2 2023.

Based on VanEck Associates's 13F filing for Q2 2023, filed 3 Aug 2023.